Dr Ravandi-Kashani on the FDA Approval of Luspatercept in MDS
Farhad Ravandi-Kashani, MD, discusses the FDA approval of luspatercept in myelodysplastic syndrome.
Source: onclive.com
Stay updated with breaking news from Stephena Lasher. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Farhad Ravandi-Kashani, MD, discusses the FDA approval of luspatercept in myelodysplastic syndrome.
VG earnings call for the period ending September 30, 2021.